sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Healthcare / Seasonal Influenza Vaccine

Seasonal Influenza Vaccine Market By Product Type (Quadrivalent, and Trivalent), By Sector (Public, and Private), End User / Sales Channel (Hospitals, Government Suppliers, and Others): Global & Regional Industry Perspective, Comprehensive Analysis, Historical Trends, and Forecasts, 2021 – 2030

  • Publish On: Sep-2021
  • Total Pages: 330
  • Report Code: FAF-1591
  • Base Year: 2020
  • Format:

Industry Insights

[330+ Pages Report] According to the report published by the Facts & Factors Research, the global Seasonal Influenza Vaccine market was estimated at approximately USD 5,638.3 Million in 2020 and is expected to generate revenue of around USD 9,801.8 Million by the end of 2030, growing at a CAGR of around 5.6% between 2021 and 2030.

Global Seasonal Influenza Vaccine Market: Overview

Influenza commonly known as flu is a viral infection that attacks the respiratory system where an infected individual suffers from muscle aches, fever, runny nose, congestion, cough, headaches, and fatigue. It is a rapid transmittable infection, spreading via sneezes and coughs of an infected individual, and can cause mild to severe sickness. 

An influenza vaccine refers to the vaccines, which protect against infection by influenza viruses. It is also known as flu jabs or flu shots. The newer versions of the influenza vaccines are developed twice a year because of rapid changes in the flu virus. An influenza vaccine causes antibodies to develop in the body about two weeks after vaccination. These antibodies provide protection against infection with the viruses that are used to make vaccines.

Global Seasonal Influenza Vaccine Market: Growth Factors

Key factors such as the growing occurrence of cancer along with the expanding research and development activities with 3D animation technology intended for visualization in novel drug development will generate the demand for animated studies to make clear the drug mechanisms is projected to drive the growth of Seasonal Influenza Vaccine market in the upcoming years. Furthermore, the growing adoption of Seasonal Influenza Vaccine methods by healthcare experts for representing medical processes or other scientific uses with much advanced understanding is likely to boost the market enlargement in Seasonal Influenza Vaccine over the analysis period. Because this technology helps in instructing patients, a rising patient enrolment in wellness programs or disease management is observed. This shows the prospective for this technology in the future. Also, Seasonal Influenza Vaccine is used for the explanation of cellular as well as molecular mechanisms, for medical simulation and recreation of any crime scene in the forensic study, and to deliver education in emergency care.

However, the high research and development cost will hamper the growth of the global Seasonal Influenza Vaccine market during the forecast period. Moreover, it needs prior guidance of the company employees to enhance their production. Conversely, the combination of Seasonal Influenza Vaccine into the mobile apps by connecting real-time media-rich content with quantifiable data and configurable tools for numerous medical device and pharmaceutical company sales are projected to generate profitable opportunities for market growth in Seasonal Influenza Vaccine in the near future.

Global Seasonal Influenza Vaccine Market: COVID-19 Impacts

The COVID-19 pandemic impacted the routine immunization programs and campaigns conducted worldwide due to lockdown conditions in developing as well as developed countries. Influenza vaccination rates increased considerably in the COVID-19 pandemic as health departments and experts along with government programs encouraged people to get vaccinated against flu while providing free vaccination against flu. E.g., the UK has planned to expand the influenza program to provide free influenza vaccine for the first time to all adults 50-64 years of age, people on the shielded patient list, and their household members and children in the first year of secondary school.

Global Seasonal Influenza Vaccine Market: Segmentations

In terms of types, the global Seasonal Influenza Vaccine market is divided into Quadrivalent and Trivalent vaccines. In 2020, the quadrivalent product category accounted for the highest revenue share. This vaccine type is designed to protect against four different flu viruses, including influenza-A and influenza-B. Factors such as high efficiency coupled with larger demand for these products to protect viruses will support the segment growth to a great extent.

Depending upon the sector, the worldwide market is categorized into public and private. The private sector is projected to grow with the fastest annual growth rate of over 6%. Whereas, the end-user chapter is broadly analyzed into Hospitals, Government Suppliers, and Others. During the year 2020, the hospital segment recorded more than USD 1.8 bn, expanding at 5% of CAGR during the study period.

Report Scope:

Report Attribute Details
Market Size in 2020 USD 5,638.3 Million
Projected Market Size in 2030 USD 9,801.8 Million
CAGR Growth Rate 5.6%
Base Year 2020
Forecast Years 2021-2030
Key Market Players Biodiem, AstraZeneca, Emergent BioSolutions, CSL Limited, Gamma Vaccines, F. Hoffmann-La Roche Ltd, Merck, Novartis, and Others
Key Segments Product Type, Sector, End-User, and Region
Major Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Purchase Options Request customized purchase options to meet your research needs. Explore purchase options

Global Seasonal Influenza Vaccine Market: Regional Analysis

The regional segment is divided into North America, Europe, Asia Pacific, the Middle East, and Africa, Latin America, and Russia & CIS. North America Seasonal Influenza Vaccine Market recorded more than 3.5 billion in 2020. This region is anticipated to dominate and hold the top position in the market in the next few years due to the rising occurrence of influenza outbreaks in countries like the U.S.

However, Asia Pacific Seasonal Influenza Vaccine Market is projected to grow with the fastest growth rate during the forecast period. The mounting disease awareness, the intensifying government support for immunization against seasonal influenza, and vast coverage for vaccination are expected to support the regional growth.

Global Seasonal Influenza Vaccine Market: Competitive Players

Various market players in the global market of Seasonal Influenza Vaccine cover AstraZeneca, Biodiem, CSL Limited, Emergent BioSolutions, F. Hoffmann-La Roche Ltd, Gamma Vaccines, GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi, Sinovac, Hualan, Abbott, Mitsubishi Tanabe Pharma, Serum Institute of India, Mylan, among others.

The worldwide seasonal influenza vaccine market is highly consolidated in nature. The worldwide market is concentrated among few international players, namely Sanofi, CSL Limited, GSK, AstraZeneca, Sinovac Biotech, and Mitsubishi Tanabe Pharma. Among these, Sanofi and GSK accounted for the highest revenue share. The company, Sanofi, is estimated to capture more than 48% share of the worldwide market. Company’s products such as Fluzone, and Flublok witnessed notable revenue in the US and Europe during the year 2021 which has supported the company’s dominant market position.    

Global Seasonal Influenza Vaccine Market: By Product Type

  • Quadrivalent
  • Trivalent

Global Seasonal Influenza Vaccine Market: By Sector

  • Public
  • Private

Global Seasonal Influenza Vaccine Market: By End-User

  • Hospitals
  • Government Suppliers
  • Others

Global Seasonal Influenza Vaccine Market: Regional Segmentation Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Turkey
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
    • Vietnam
    • Philippines
    • Mongolia
    • Malaysia
    • Indonesia
    • Nepal
    • Taiwan
    • Bangladesh
    • Pakistan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • The Middle East and Africa
    • Saudi Arabia
    • Iran
    • Iraq
    • Egypt
    • UAE
    • Morocco
    • Tunisia
    • Algeria
    • South Africa
    • Rest of Middle East Africa
  • Russia & CIS
    • Ukraine
    • Moldova
    • Georgia
    • Uzbekistan
    • Azerbaijan
    • Saudi Arabia

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable  Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises a buoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. Chapter 1 Executive Summary
    1. 1.1. Introduction of Seasonal Influenza Vaccine
    2. 1.2. COVID-19 Impacts on Influenza Vaccine Industry
      1. 1.2.1. COVID-19 Short-Term Impact & Business Strategies
      2. 1.2.2. COVID-19 Mid-Term Impact & Business Strategies
      3. 1.2.3. COVID-19 Long-Term Impact & Business Strategies
    3. 1.3. Global Seasonal Influenza Vaccine Market, 2020 & 2030 (USD Million)
    4. 1.4. Global Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million) (Million Units)
  2. Chapter 2 Seasonal Influenza Vaccine Market – Types Analysis
    1. 2.1. Global Seasonal Influenza Vaccine Market – Types Overview
    2. 2.2. Global Seasonal Influenza Vaccine Market Share, by Types, 2020 & 2030 (USD Million)
    3. 2.3. Global Seasonal Influenza Vaccine Market share, by Types, 2020 & 2030 (Million Units)
    4. 2.4. Quadrivalent
      1. 2.4.1. Global Quadrivalent Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      2. 2.4.2. Global Quadrivalent Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
    5. 2.5. Trivalent
      1. 2.5.1. Global Trivalent Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      2. 2.5.2. Global Trivalent Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
  3. Chapter 3 Seasonal Influenza Vaccine Market – Sales Channel Analysis
    1. 3.1. Global Seasonal Influenza Vaccine Market – Sales Channel Overview
    2. 3.2. Global Seasonal Influenza Vaccine Market Share, by Sales Channel, 2020 & 2030 (USD Million)
    3. 3.3. Global Seasonal Influenza Vaccine Market share, by Sales Channel, 2020 & 2030 (Million Units)
    4. 3.4. Hospitals
      1. 3.4.1. Global Hospitals Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      2. 3.4.2. Global Hospitals Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
    5. 3.5. Government Suppliers
      1. 3.5.1. Global Government Suppliers Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      2. 3.5.2. Global Government Suppliers Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
    6. 3.6. Others
      1. 3.6.1. Global Government Suppliers Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      2. 3.6.2. Global Others Sales Channel Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
  4. Chapter 4 Seasonal Influenza Vaccine Market – Sector Analysis
    1. 4.1. Global Seasonal Influenza Vaccine Market – Sector Overview
    2. 4.2. Global Seasonal Influenza Vaccine Market Share, by Sector, 2020 & 2030 (USD Million)
    3. 4.3. Global Seasonal Influenza Vaccine Market share, by Sector, 2020 & 2030 (Million Units)
    4. 4.4. Public
      1. 4.4.1. Global Public Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      2. 4.4.2. Global Public Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
    5. 4.5. Awarded Price, Awardee, NIP Coverage, Flu Campaign Period
      1. 4.5.1. Awarded Price and Awardee
      2. 4.5.2. NIP Coverage
      3. 4.5.3. Flu Campaign Period
    6. 4.6. Private
      1. 4.6.1. Global Private Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      2. 4.6.2. Global Private Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      3. 4.6.3. Price (per segments) by Product
        1. 4.6.3.1. NA Quadrivalent Average Pricing Analysis
        2. 4.6.3.2. NA Trivalent Average Pricing Analysis
        3. 4.6.3.3. EU Quadrivalent Average Pricing Analysis
        4. 4.6.3.4. EU Trivalent Average Pricing Analysis
        5. 4.6.3.5. APAC Quadrivalent Average Pricing Analysis
        6. 4.6.3.6. APAC Trivalent Average Pricing Analysis
        7. 4.6.3.7. LATAM Quadrivalent Average Pricing Analysis
        8. 4.6.3.8. LATAM Trivalent Average Pricing Analysis
        9. 4.6.3.9. MEA Quadrivalent Average Pricing Analysis
        10. 4.6.3.10. MEA Trivalent Average Pricing Analysis
      4. 4.6.4. Private Distributor information for Seasonal Influenza Vaccine, by Manufacturer
  5. Chapter 5 Seasonal Influenza Vaccine Market – Regional Analysis
    1. 5.1. Global Seasonal Influenza Vaccine Market Regional Overview
    2. 5.2. Global Seasonal Influenza Vaccine Market Share, by Region, 2020 & 2030 (USD Million)
    3. 5.3. Global Seasonal Influenza Vaccine Market Share, by Region, 2020 & 2030 (Million Units)
    4. 5.4. North America
      1. 5.4.1. North America Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        1. 5.4.1.1. North America Seasonal Influenza Vaccine Market, by Country, 2010 – 2030 (USD Million)
      2. 5.4.2. North America Market, 2010 – 2030 (Million Units)
        1. 5.4.2.1. North America Seasonal Influenza Vaccine Market, by Country, 2010 – 2030 (Million Units)
      3. 5.4.3. North America Seasonal Influenza Vaccine Market, by Types, 2010 – 2030
      4. 5.4.4. North America Seasonal Influenza Vaccine Market, by Sales Channel, 2010 – 2030
      5. 5.4.5. North America Seasonal Influenza Vaccine Market, by Sector, 2010 – 2030
      6. 5.4.6. U.S.
        1. 5.4.6.1. U.S. Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.4.6.2. U.S. Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      7. 5.4.7. Canada
        1. 5.4.7.1. Canada Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.4.7.2. Canada Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
    5. 5.5. Europe
      1. 5.5.1. Europe Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        1. 5.5.1.1. Europe Seasonal Influenza Vaccine Market, by Country, 2010 – 2030 (USD Million)
      2. 5.5.2. Europe Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
        1. 5.5.2.1. Europe Seasonal Influenza Vaccine Market, by Country, 2010 – 2030 (Million Units)
      3. 5.5.3. Europe Seasonal Influenza Vaccine Market, by Types, 2010 – 2030
      4. 5.5.4. Europe Seasonal Influenza Vaccine Market, by Sales Channel, 2010 – 2030
      5. 5.5.5. Europe Seasonal Influenza Vaccine Market, by Sector, 2010 – 2030
      6. 5.5.6. Germany
        1. 5.5.6.1. Germany Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.5.6.2. Germany Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      7. 5.5.7. France
        1. 5.5.7.1. France Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.5.7.2. France Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      8. 5.5.8. U.K.
        1. 5.5.8.1. U.K. Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.5.8.2. U.K. Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      9. 5.5.9. Turkey
        1. 5.5.9.1. Turkey Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.5.9.2. Turkey Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      10. 5.5.10. Spain
        1. 5.5.10.1. Spain Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.5.10.2. Spain Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      11. 5.5.11. Rest of Europe
        1. 5.5.11.1. Rest of Europe Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.5.11.2. Rest of Europe Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
    6. 5.6. Asia Pacific
      1. 5.6.1. Asia Pacific Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        1. 5.6.1.1. Asia Pacific Seasonal Influenza Vaccine Market, by Country, 2010 – 2030 (USD Million)
      2. 5.6.2. Asia Pacific Market, 2010 – 2030 (Million Units)
        1. 5.6.2.1. Asia Pacific Seasonal Influenza Vaccine Market, by Country, 2010 – 2030 (Million Units)
      3. 5.6.3. Asia Pacific Seasonal Influenza Vaccine Market, by Types, 2010 – 2030
      4. 5.6.4. Asia Pacific Seasonal Influenza Vaccine Market, by Sales Channel, 2010 – 2030
      5. 5.6.5. Asia Pacific Seasonal Influenza Vaccine Market, by Sector, 2010 – 2030
      6. 5.6.6. China
        1. 5.6.6.1. China Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.6.6.2. China Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      7. 5.6.7. Japan
        1. 5.6.7.1. Japan Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.6.7.2. Japan Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      8. 5.6.8. India
        1. 5.6.8.1. India Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.6.8.2. India Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      9. 5.6.9. South Korea
        1. 5.6.9.1. South Korea Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.6.9.2. South Korea Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      10. 5.6.10. Thailand
        1. 5.6.10.1. Thailand Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.6.10.2. Thailand Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      11. 5.6.11. Vietnam
        1. 5.6.11.1. Vietnam Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.6.11.2. Vietnam Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      12. 5.6.12. Philippines
        1. 5.6.12.1. Philippines Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.6.12.2. Philippines Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      13. 5.6.13. Mongolia
        1. 5.6.13.1. Mongolia Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.6.13.2. Mongolia Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      14. 5.6.14. Malaysia
        1. 5.6.14.1. Malaysia Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.6.14.2. Malaysia Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      15. 5.6.15. Indonesia
        1. 5.6.15.1. Indonesia Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.6.15.2. Indonesia Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      16. 5.6.16. Nepal
        1. 5.6.16.1. Nepal Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.6.16.2. Nepal Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      17. 5.6.17. Taiwan
        1. 5.6.17.1. Taiwan Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.6.17.2. Taiwan Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      18. 5.6.18. Bangladesh
        1. 5.6.18.1. Bangladesh Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.6.18.2. Bangladesh Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      19. 5.6.19. Pakistan
        1. 5.6.19.1. Pakistan Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.6.19.2. Pakistan Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      20. 5.6.20. Rest of Asia Pacific
        1. 5.6.20.1. Rest of Asia Pacific Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.6.20.2. Rest of Asia Pacific Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
    7. 5.7. Latin America
      1. 5.7.1. Latin America Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        1. 5.7.1.1. Latin America Seasonal Influenza Vaccine Market, by Country, 2010 – 2030 (USD Million)
      2. 5.7.2. Latin America Market, 2010 – 2030 (Million Units)
      3. 5.7.3. Latin America Seasonal Influenza Vaccine Market, by Types, 2010 – 2030
      4. 5.7.4. Latin America Seasonal Influenza Vaccine Market, by Sales Channel, 2010 – 2030
      5. 5.7.5. Latin America Seasonal Influenza Vaccine Market, by Sector, 2010 – 2030
      6. 5.7.6. Brazil
        1. 5.7.6.1. Brazil Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.7.6.2. Brazil Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      7. 5.7.7. Mexico
        1. 5.7.7.1. Mexico Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.7.7.2. Mexico Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      8. 5.7.8. Argentina
        1. 5.7.8.1. Argentina Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.7.8.2. Argentina Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      9. 5.7.9. Rest of Latin America
        1. 5.7.9.1. Rest of Latin America Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.7.9.2. Rest of Latin America Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
    8. 5.8. Middle-East and Africa
      1. 5.8.1. Middle-East and Africa Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      2. 5.8.2. Middle-East and Africa Market, 2010 – 2030 (Million Units)
        1. 5.8.2.1. Middle-East and Africa Seasonal Influenza Vaccine Market, by Country, 2010 – 2030
      3. 5.8.3. Middle East and Africa Seasonal Influenza Vaccine Market, by Types, 2010 – 2030
      4. 5.8.4. Middle East and Africa Seasonal Influenza Vaccine Market, by Sales Channel, 2010 – 2030
      5. 5.8.5. Middle East and Africa Seasonal Influenza Vaccine Market, by Sector, 2010 – 2030
      6. 5.8.6. Saudi Arabia
        1. 5.8.6.1. Saudi Arabia Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.8.6.2. Saudi Arabia Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      7. 5.8.7. Iran
        1. 5.8.7.1. Iran Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.8.7.2. Iran Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      8. 5.8.8. Iraq
        1. 5.8.8.1. Iraq Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.8.8.2. Iraq Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      9. 5.8.9. Egypt
        1. 5.8.9.1. Egypt Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.8.9.2. Egypt Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      10. 5.8.10. UAE
        1. 5.8.10.1. UAE Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.8.10.2. UAE Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      11. 5.8.11. Morocco
        1. 5.8.11.1. Morocco Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.8.11.2. Morocco Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      12. 5.8.12. Tunisia
        1. 5.8.12.1. Tunisia Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.8.12.2. Tunisia Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      13. 5.8.13. Algeria
        1. 5.8.13.1. Algeria Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.8.13.2. Algeria Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      14. 5.8.14. South Africa
        1. 5.8.14.1. South Africa Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.8.14.2. South Africa Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      15. 5.8.15. Rest of Middle-East Africa
        1. 5.8.15.1. Rest of Middle-East Africa Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.8.15.2. Rest of Middle-East Africa Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
        3. 5.8.15.3. Rest of Middle-East Africa Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
    9. 5.9. Russia & CIS
      1. 5.9.1. Russia & CIS Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      2. 5.9.2. Russia & CIS Market, 2010 – 2030 (Million Units)
        1. 5.9.2.1. Russia & CIS Seasonal Influenza Vaccine Market, by Country, 2010 – 2030
      3. 5.9.3. Russia & CIS Seasonal Influenza Vaccine Market, by Types, 2010 – 2030
      4. 5.9.4. Russia & CIS Seasonal Influenza Vaccine Market, by Sales Channel, 2010 – 2030
      5. 5.9.5. Russia & CIS Seasonal Influenza Vaccine Market, by Sector, 2010 – 2030
      6. 5.9.6. Ukraine
        1. 5.9.6.1. Ukraine Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.9.6.2. Ukraine Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      7. 5.9.7. Moldova
        1. 5.9.7.1. Moldova Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.9.7.2. Moldova Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      8. 5.9.8. Georgia
        1. 5.9.8.1. Georgia Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.9.8.2. Georgia Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      9. 5.9.9. Uzbekistan
        1. 5.9.9.1. Uzbekistan Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.9.9.2. Uzbekistan Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      10. 5.9.10. Azerbaijan
        1. 5.9.10.1. Azerbaijan Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
        2. 5.9.10.2. Azerbaijan Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
  6. Chapter 6 Seasonal Influenza Vaccine Market – Competitive Landscape
    1. 6.1. Competitor Market Share – Revenue
    2. 6.2. On-going projects for Local Manufacturing Players
    3. 6.3. Local Vaccine Manufacturer Analysis
    4. 6.4. Competitor Market Share – Volume
    5. 6.5. Strategic Developments
      1. 6.5.1. Acquisitions and Mergers
      2. 6.5.2. New Products
      3. 6.5.3. Research & Development Activities
  7. Chapter 7 Company Profiles
    1. 7.1. AstraZeneca
      1. 7.1.1. Company Profile
      2. 7.1.2. Product Portfolio
      3. 7.1.3. AstraZeneca Sales, Revenue, and Gross Margin
      4. 7.1.4. AstraZeneca Revenue
      5. 7.1.5. AstraZeneca Market Share
      6. 7.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    2. 7.2. Biodiem
      1. 7.2.1. Company Profile
      2. 7.2.2. Product Portfolio
      3. 7.2.3. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    3. 7.3. CSL Limited
      1. 7.3.1. Company Profile
      2. 7.3.2. Product Portfolio
      3. 7.3.3. CSL Limited Sales, Revenue, and Gross Margin
      4. 7.3.4. CSL Limited Revenue
      5. 7.3.5. CSL Limited Market Share
      6. 7.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    4. 7.4. Emergent BioSolutions
      1. 7.4.1. Company Profile
      2. 7.4.2. Product Portfolio
      3. 7.4.3. Recent Initiatives, Funding/VC Activities, and Technological Innovations
      4. 7.5. F. Hoffmann-La Roche Ltd
      5. 7.5.1. Company Profile
      6. 7.5.2. Product Portfolio
      7. 7.5.3. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    5. 7.6. Gamma Vaccines
      1. 7.6.1. Company Profile
      2. 7.6.2. Product Portfolio
    6. 7.7. GlaxoSmithKline
      1. 7.7.1. Company Profile
      2. 7.7.2. Product Portfolio
      3. 7.7.3. GlaxoSmithKline Sales, Revenue, and Gross Margin
      4. 7.7.4. GlaxoSmithKline Revenue
      5. 7.7.5. GlaxoSmithKline Market Share
      6. 7.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    7. 7.8. Merck & Co., Inc.
      1. 7.8.1. Company Profile
      2. 7.8.2. Product Portfolio
      3. 7.8.3. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    8. 7.9. Novartis
      1. 7.9.1. Company Profile
      2. 7.9.2. Product Portfolio
      3. 7.9.3. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    9. 7.10. Pfizer
      1. 7.10.1. Company Profile
      2. 7.10.2. Product Portfolio
      3. 7.10.3. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    10. 7.11. Sanofi
      1. 7.11.1. Company Profile
      2. 7.11.2. Product Portfolio
      3. 7.11.3. Sanofi Sales, Revenue, and Gross Margin
      4. 7.11.4. Sanofi Revenue
      5. 7.11.5. Sanofi Market Share
      6. 7.11.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    11. 7.12. Sinovac Biotech
      1. 7.12.1. Company Profile
      2. 7.12.2. Product Portfolio
      3. 7.12.3. Sinovac Biotech Sales, Revenue, and Gross Margin
      4. 7.12.4. Sinovac Biotech Revenue
      5. 7.12.5. Sinovac Biotech Market Share
      6. 7.12.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    12. 7.13. Hualan Bio
      1. 7.13.1. Company Profile
      2. 7.13.2. Product Portfolio
    13. 7.14. Changchun Beike Biotechnology Co., Ltd.
      1. 7.14.1. Company Profile
      2. 7.14.2. Product Portfolio
    14. 7.15. Abbott Laboratories
      1. 7.15.1. Company Profile
      2. 7.15.2. Product Portfolio
      3. 7.15.3. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    15. 7.16. Mitsubishi Tanabe Pharma Corporation
      1. 7.16.1. Company Profile
      2. 7.16.2. Product Portfolio
      3. 7.16.3. Mitsubishi Tanabe Pharma Corporation Sales, Revenue, and Gross Margin
      4. 7.16.4. Mitsubishi Tanabe Pharma Corporation Revenue
      5. 7.16.5. Mitsubishi Tanabe Pharma Corporation Market Share
      6. 7.16.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    16. 7.17. Serum Institute of India Pvt. Ltd.
      1. 7.17.1. Company Profile
      2. 7.17.2. Product Portfolio
    17. 7.18. Mylan
      1. 7.18.1. Company Profile
      2. 7.18.2. Product Portfolio
      3. 7.18.3. Recent Initiatives, Funding/VC Activities, and Technological Innovations
  8. Chapter 8 Seasonal Influenza Vaccine — Industry Analysis
    1. 8.1. Seasonal Influenza Vaccine Market – Key Trends
      1. 8.1.1. Market Drivers
      2. 8.1.2. Market Restraints
      3. 8.1.3. Market Opportunities
    2. 8.2. Value Chain Analysis
      1. 8.2.1. Tasks carried out at flu vaccine manufacturers
    3. 8.3. Key Mandates and Regulations
    4. 8.4. Seasonal Influenza Vaccine Market – Attractiveness Analysis
      1. 8.4.1. By Types
      2. 8.4.2. By Sector
      3. 8.4.3. By Sales Channel
      4. 8.4.4. By Region
  9. Chapter 9 Industrial Chain, Sourcing Strategy, and Downstream Buyers
    1. 9.1. Seasonal Influenza Vaccine Industrial Chain Analysis
    2. 9.2. Upstream Raw Materials Sourcing
      1. 9.2.1. Risk Mitigation:
      2. 9.2.2. Supplier Relationships:
      3. 9.2.3. Business Processes:
      4. 9.2.4. Securing the Product:
    3. 9.3. Raw Materials Sources of Seasonal Influenza Vaccine Major Manufacturers
    4. 9.4. Downstream Buyers
    5. 9.5. Distributors/Traders List
  10. Chapter 10 Marketing Strategy Analysis, Distributors
    1. 10.1. Marketing Channel
    2. 10.2. Direct and Indirect Marketing
    3. 10.3. Marketing Channel Development Trends
  11. Chapter 11 Report Conclusion & Key Insights
    1. 11.1. Key Insights from Primary Interviews & Survey Respondents
    2. 11.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  12. Chapter 12 Research Approach & Methodology
    1. 12.1. Report Description
    2. 12.2. Research Scope
    3. 12.3. Research Methodology
      1. 12.3.1. Research Methodology for Seasonal Influenza Vaccine Market Estimation
      2. 12.3.2. Secondary Research
      3. 12.3.3. Primary Research
      4. 12.3.4. Statistical Models
        1. 12.3.4.1. Company Share Analysis Model
        2. 12.3.4.2. Revenue Based Modeling
      5. 12.3.5. Research Limitations

      List of Figures

      Fig.1	Product Picture of Seasonal Influenza Vaccine
      Fig.2	Global Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.3	Global Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      Fig.4	Global Seasonal Influenza Vaccine Market Share, by Types, 2020 & 2030 (USD Million)
      Fig.5	Global Seasonal Influenza Vaccine Market Share, by Types, 2020 & 2030 (Million Units)
      Fig.6	Global Quadrivalent Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.7	Global Quadrivalent Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      Fig.8	Global Trivalent Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.9	Global Trivalent Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      Fig.10	Global Seasonal Influenza Vaccine Market Share, by Sales Channel, 2020 & 2030 (USD Million)
      Fig.11	Global Seasonal Influenza Vaccine Market Share, by Sales Channel, 2020 & 2030 (Million Units)
      Fig.12	Global Hospitals Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.13	Global Hospitals Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      Fig.14	Global Government Suppliers Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.15	Global Government Suppliers Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      Fig.16	Global Government Suppliers Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.17	Global Others Sales Channel Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      Fig.18	Global Seasonal Influenza Vaccine Market Share, by Sector, 2020 & 2030 (USD Million)
      Fig.19	Global Seasonal Influenza Vaccine Market Share, by Sector, 2020 & 2030 (Million Units)
      Fig.20	Global Public Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.21	Global Public Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      Fig.22	Global Private Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.23	Global Private Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      Fig.24	Global Seasonal Influenza Vaccine Market Share, by Region, 2020 & 2030 (USD Million)
      Fig.25	Global Seasonal Influenza Vaccine Market Share, by Region, 2020 & 2030 (Million Units)
      Fig.26	North America Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.27	North America Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      Fig.28	U.S. Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.29	U.S. Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.30	Canada Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.31	Canada Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.32	Europe Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.33	Europe Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      Fig.34	Germany Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.35	Germany Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.36	France Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.37	France Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.38	U.K. Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.39	U.K. Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.40	Turkey Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.41	Turkey Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.42	Spain Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.43	Spain Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.44	Rest of Europe Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.45	Rest of Europe Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.46	Asia Pacific Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.47	Asia Pacific Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      Fig.48	China Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.49	China Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.50	Japan Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.51	Japan Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.52	India Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.53	India Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.54	South Korea Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.55	South Korea Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.56	Thailand Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.57	Thailand Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.58	Vietnam Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.59	Vietnam Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.60	Philippines Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.61	Philippines Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.62	Mongolia Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.63	Mongolia Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.64	Malaysia Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.65	Malaysia Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.66	Indonesia Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.67	Indonesia Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.68	Nepal Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.69	Nepal Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.70	Taiwan Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.71	Taiwan Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.72	Bangladesh Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.73	Bangladesh Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.74	Pakistan Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.75	Pakistan Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.76	Rest of Asia Pacific Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.77	Rest of Asia Pacific Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.78	Latin America Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.79	Latin America Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      Fig.80	Brazil Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.81	Brazil Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.82	Mexico Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.83	Mexico Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.84	Argentina Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.85	Argentina Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.86	Rest of Latin America Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.87	Rest of Latin America Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.88	The Middle-East and Africa Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.89	The Middle-East and Africa Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      Fig.90	Saudi Arabia Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.91	Saudi Arabia Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.92	Iran Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.93	Iran Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.94	Iraq Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.95	Iraq Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.96	Egypt Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.97	Egypt Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.98	UAE Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.99	UAE Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.100	Morocco Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.101	Morocco Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.102	Tunisia Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.103	Tunisia Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.104	Algeria Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.105	Algeria Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.106	South Africa Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.107	South Africa Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.108	Rest of Middle-East Africa Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.109	Russia & CIS Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.110	Russia & CIS Seasonal Influenza Vaccine Market, 2010 – 2030 (Million Units)
      Fig.111	Ukraine Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.112	Ukraine Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.113	Moldova Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.114	Moldova Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.115	Georgia Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.116	Georgia Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.117	Uzbekistan Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.118	Uzbekistan Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.119	Azerbaijan Seasonal Influenza Vaccine Market, 2010 – 2030 (USD Million)
      Fig.120	Azerbaijan Seasonal Influenza Vaccine  Market, 2010 – 2030 (Million Units)
      Fig.121	Competitor Market Share – Revenue
      Fig.122	Competitor Market Share – Volume
      Fig.123	AstraZeneca Revenue
      Fig.124	AstraZeneca Market Share
      Fig.125	CSL Limited Revenue
      Fig.126	CSL Limited Market Share
      Fig.127	GlaxoSmithKline Revenue
      Fig.128	GlaxoSmithKline Market Share
      Fig.129	Sanofi Revenue
      Fig.130	Sanofi Market Share
      Fig.131	Sinovac Biotech Revenue
      Fig.132	Sinovac Biotech Market Share
      Fig.133	Mitsubishi Tanabe Pharma Corporation Revenue
      Fig.134	Mitsubishi Tanabe Pharma Corporation Market Share
      Fig.135	Market Attractiveness Analysis – By Types
      Fig.136	Market Attractiveness Analysis – By Sector
      Fig.137	Market Attractiveness Analysis – By Sales Channel
      Fig.138	Market Attractiveness Analysis – By Region
      Fig.139	Seasonal Influenza Vaccine Industrial Chain Analysis
      Fig.140	Market Channels
      

      List of Tables

      Table 1	Global Seasonal Influenza Vaccine Market, 2020 & 2030 (USD Million)
      Table 2	Global Seasonal Influenza Vaccine Market (Historic Data), by Types, 2010 – 2020 (USD Million)
      Table 3	Global Seasonal Influenza Vaccine Market (Forecast Data), by Types, 2021 – 2030 (USD Million)
      Table 4	Global Seasonal Influenza Vaccine Market (Historic Data), by Types, 2010 – 2020 (Million Units)
      Table 5	Global Seasonal Influenza Vaccine Market (Forecast Data), by Types, 2021 – 2030 (Million Units)
      Table 6	Global Seasonal Influenza Vaccine Market (Historic Data), by Sales Channel, 2010 – 2020 (USD Million)
      Table 7	Global Seasonal Influenza Vaccine Market (Forecast Data), by Sales Channel, 2021 – 2030 (USD Million)
      Table 8	Global Seasonal Influenza Vaccine Market (Historic Data), by Sales Channel, 2010 – 2020 (Million Units)
      Table 9	Global Seasonal Influenza Vaccine Market (Forecast Data), by Sales Channel, 2021 – 2030 (Million Units)
      Table 10 Global Seasonal Influenza Vaccine Market (Historic Data), by Sector, 2010 – 2020 (USD Million)
      Table 11 Global Seasonal Influenza Vaccine Market (Forecast Data), by Sector, 2021 – 2030 (USD Million)
      Table 12 Global Seasonal Influenza Vaccine Market (Historic Data), by Sector, 2010 – 2020 (Million Units)
      Table 13 Global Seasonal Influenza Vaccine Market (Forecast Data), by Sector, 2021 – 2030 (Million Units)
      Table 14 U.S. Pediatric Influenza Vaccine Price and Awardee (2021-2022)
      Table 15 U.S. Adult Influenza Vaccine Price and Awardee (2021-2022)
      Table 16 Private Distributor information for Seasonal Influenza Vaccine (USD Million)
      Table 17 Global Seasonal Influenza Vaccine Market (Historic Data), by Region, 2010 – 2020 (USD Million)
      Table 18 Global Seasonal Influenza Vaccine Market (Forecast Data), by Region, 2021 – 2030 (USD Million)
      Table 19 Global Seasonal Influenza Vaccine Market (Historic Data), by Region, 2010 – 2020 (Million Units)
      Table 20 Global Seasonal Influenza Vaccine Market (Forecast Data), by Region, 2021 – 2030 (Million Units)
      Table 21 North America Seasonal Influenza Vaccine Market (Historic Data), by Country, 2010 – 2020 (USD Million)
      Table 22 North America Seasonal Influenza Vaccine Market (Forecast Data), by Country, 2021 – 2030 (USD Million)
      Table 23 North America Seasonal Influenza Vaccine Market (Historic Data), by Country, 2010 – 2020 (Million Units)
      Table 24 North America Seasonal Influenza Vaccine Market (Forecast Data), by Country, 2021 – 2030 (Million Units)
      Table 25 North America Seasonal Influenza Vaccine Market (Historic Data), by Types, 2010 – 2020 (USD Million)
      Table 26 North America Seasonal Influenza Vaccine Market (Forecast Data), by Types, 2021 – 2030 (USD Million)
      Table 27 North America Seasonal Influenza Vaccine Market (Historic Data), by Types, 2010 – 2020 (Million Units)
      Table 28 North America Seasonal Influenza Vaccine Market (Forecast Data), by Types, 2021 – 2030 (Million Units)
      Table 29 North America Seasonal Influenza Vaccine Market (Historic Data), by Sales Channel, 2010 – 2020 (USD Million)
      Table 30 North America Seasonal Influenza Vaccine Market (Forecast Data), by Sales Channel, 2021 – 2030 (USD Million)
      Table 31 North America Seasonal Influenza Vaccine Market (Historic Data), by Sales Channel, 2010 – 2020 (Million Units)
      Table 32 North America Seasonal Influenza Vaccine Market (Forecast Data), by Sales Channel, 2021 – 2030 (Million Units)
      Table 33 North America Seasonal Influenza Vaccine Market (Historic Data), by Sector, 2010 – 2020 (USD Million)
      Table 34 North America Seasonal Influenza Vaccine Market (Forecast Data), by Sector, 2021 – 2030 (USD Million)
      Table 35 North America Seasonal Influenza Vaccine Market (Historic Data), by Sector, 2010 – 2020 (Million Units)
      Table 36 North America Seasonal Influenza Vaccine Market (Forecast Data), by Sector, 2021 – 2030 (Million Units)
      Table 37 Europe Seasonal Influenza Vaccine Market (Historic Data), by Region, 2010 – 2020 (USD Million)
      Table 38 Europe Seasonal Influenza Vaccine Market (Forecast Data), by Region, 2021 – 2030 (USD Million)
      Table 39 Europe Seasonal Influenza Vaccine Market (Historic Data), by Region, 2010 – 2020 (Million Units)
      Table 40 Europe Seasonal Influenza Vaccine Market (Forecast Data), by Region, 2021 – 2030 (Million Units)
      Table 41 Europe Seasonal Influenza Vaccine Market (Historic Data), by Types, 2010 – 2020 (USD Million)
      Table 42 Europe Seasonal Influenza Vaccine Market (Forecast Data), by Types, 2021 – 2030 (USD Million)
      Table 43 Europe Seasonal Influenza Vaccine Market (Historic Data), by Types, 2010 – 2020 (Million Units)
      Table 44 Europe Seasonal Influenza Vaccine Market (Forecast Data), by Types, 2021 – 2030 (Million Units)
      Table 45 Europe Seasonal Influenza Vaccine Market (Historic Data), by Sales Channel, 2010 – 2020 (USD Million)
      Table 46 Europe Seasonal Influenza Vaccine Market (Forecast Data), by Sales Channel, 2021 – 2030 (USD Million)
      Table 47 Europe Seasonal Influenza Vaccine Market (Historic Data), by Sales Channel, 2010 – 2020 (Million Units)
      Table 48 Europe Seasonal Influenza Vaccine Market (Forecast Data), by Sales Channel, 2021 – 2030 (Million Units)
      Table 49 Europe Seasonal Influenza Vaccine Market (Historic Data), by Sector, 2010 – 2020 (USD Million)
      Table 50 Europe Seasonal Influenza Vaccine Market (Forecast Data), by Sector, 2021 – 2030 (USD Million)
      Table 51 Europe Seasonal Influenza Vaccine Market (Historic Data), by Sector, 2010 – 2020 (Million Units)
      Table 52 Europe Seasonal Influenza Vaccine Market (Forecast Data), by Sector, 2021 – 2030 (Million Units)
      Table 53 Asia Pacific Seasonal Influenza Vaccine Market (Historic Data), by Country, 2010 – 2030 (USD Million)
      Table 54 Asia Pacific Seasonal Influenza Vaccine Market (Forecast Data), by Country, 2021 – 2030 (USD Million)
      Table 55 Asia Pacific Seasonal Influenza Vaccine Market (Historic Data), by Country, 2010 – 2020 (Million Units)
      Table 56 Asia Pacific Seasonal Influenza Vaccine Market (Forecast Data), by Country, 2021 – 2030 (Million Units)
      Table 57 Asia Pacific Seasonal Influenza Vaccine Market (Historic Data), by Types, 2010 – 2030 (USD Million)
      Table 58 Asia Pacific Seasonal Influenza Vaccine Market (Forecast Data), by Types, 2021 – 2030 (USD Million)
      Table 59 Asia Pacific Seasonal Influenza Vaccine Market (Historic Data), by Types, 2010 – 2020 (Million Units)
      Table 60 Asia Pacific Seasonal Influenza Vaccine Market (Forecast Data), by Types, 2021 – 2030 (Million Units)
      Table 61 Asia Pacific Seasonal Influenza Vaccine Market (Historic Data), by Sales Channel, 2010 – 2020 (USD Million)
      Table 62 Asia Pacific Seasonal Influenza Vaccine Market (Forecast Data), by Sales Channel, 2021 – 2030 (USD Million)
      Table 63 Asia Pacific Seasonal Influenza Vaccine Market (Historic Data), by Sales Channel, 2010 – 2020 (Million Units)
      Table 64 Asia Pacific Seasonal Influenza Vaccine Market (Forecast Data), by Sales Channel, 2021 – 2030 (Million Units)
      Table 65 Asia Pacific Seasonal Influenza Vaccine Market (Historic Data), by Sector, 2010 – 2020 (USD Million)
      Table 66 Asia Pacific Seasonal Influenza Vaccine Market (Forecast Data), by Sector, 2021 – 2030 (USD Million)
      Table 67 Asia Pacific Seasonal Influenza Vaccine Market (Historic Data), by Sector, 2010 – 2020 (Million Units)
      Table 68 Asia Pacific Seasonal Influenza Vaccine Market (Forecast Data), by Sector, 2021 – 2030 (Million Units)
      Table 69 Latin America Seasonal Influenza Vaccine Market (Historic Data), by Region, 2010 – 2020 (USD Million)
      Table 70 Latin America Seasonal Influenza Vaccine Market (Forecast Data), by Region, 2021 – 2030 (USD Million)
      Table 71 Latin America Seasonal Influenza Vaccine Market (Historic Data), by Region, 2010 – 2020 (No. Units)
      Table 72 Latin America Seasonal Influenza Vaccine Market (Forecast Data), by Region, 2021 – 2030 (No. Units)
      Table 73 Latin America Seasonal Influenza Vaccine Market (Historic Data), by Types, 2010 – 2030 (USD Million)
      Table 74 Latin America Seasonal Influenza Vaccine Market (Forecast Data), by Types, 2021 – 2030 (USD Million)
      Table 75 Latin America Seasonal Influenza Vaccine Market (Historic Data), by Types, 2010 – 2020 (Million Units)
      Table 76 Latin America Seasonal Influenza Vaccine Market (Forecast Data), by Types, 2021 – 2030 (Million Units)
      Table 77 Latin America Seasonal Influenza Vaccine Market (Historic Data), by Sales Channel, 2010 – 2020 (USD Million)
      Table 78 Latin America Seasonal Influenza Vaccine Market (Forecast Data), by Sales Channel, 2021 – 2030 (USD Million)
      Table 79 Latin America Seasonal Influenza Vaccine Market (Historic Data), by Sales Channel, 2010 – 2020 (Million Units)
      Table 80 Latin America Seasonal Influenza Vaccine Market (Forecast Data), by Sales Channel, 2021 – 2030 (Million Units)
      Table 81 Latin America Seasonal Influenza Vaccine Market (Historic Data), by Sector, 2010 – 2020 (USD Million)
      Table 82 Latin America Seasonal Influenza Vaccine Market (Forecast Data), by Sector, 2021 – 2030 (USD Million)
      Table 83 Latin America Seasonal Influenza Vaccine Market (Historic Data), by Sector, 2010 – 2020 (Million Units)
      Table 84 Latin America Seasonal Influenza Vaccine Market (Forecast Data), by Sector, 2021 – 2030 (Million Units)
      Table 85 MEA Seasonal Influenza Vaccine Market (Historic Data), by Region, 2010 – 2020 (USD Million)
      Table 86 MEA Seasonal Influenza Vaccine Market (Forecast Data), by Region, 2021 – 2030 (USD Million)
      Table 87 MEA Seasonal Influenza Vaccine Market (Historic Data), by Region, 2010 – 2020 (Million Units)
      Table 88 MEA Seasonal Influenza Vaccine Market (Forecast Data), by Region, 2021 – 2030 (Million Units)
      Table 89 Middle East and Africa Seasonal Influenza Vaccine Market (Historic Data), by Types, 2010 – 2030 (USD Million)
      Table 90 Middle East and Africa Seasonal Influenza Vaccine Market (Forecast Data), by Types, 2021 – 2030 (USD Million)
      Table 91 Middle East and Africa Seasonal Influenza Vaccine Market (Historic Data), by Types, 2010 – 2020 (Million Units)
      Table 92 Middle East and Africa Seasonal Influenza Vaccine Market (Forecast Data), by Types, 2021 – 2030 (Million Units)
      Table 93 Middle East and Africa Seasonal Influenza Vaccine Market (Historic Data), by Sales Channel, 2010 – 2020 (USD Million)
      Table 94 Middle East and Africa Seasonal Influenza Vaccine Market (Forecast Data), by Sales Channel, 2021 – 2030 (USD Million)
      Table 95 Middle East and Africa Seasonal Influenza Vaccine Market (Historic Data), by Sales Channel, 2010 – 2020 (Million Units)
      Table 96 Middle East and Africa Seasonal Influenza Vaccine Market (Forecast Data), by Sales Channel, 2021 – 2030 (Million Units)
      Table 97 Middle East and Africa Seasonal Influenza Vaccine Market (Historic Data), by Sector, 2010 – 2020 (USD Million)
      Table 98 Middle East and Africa Seasonal Influenza Vaccine Market (Forecast Data), by Sector, 2021 – 2030 (USD Million)
      Table 99 Middle East and Africa Seasonal Influenza Vaccine Market (Historic Data), by Sector, 2010 – 2020 (Million Units)
      Table 100 Middle East and Africa Seasonal Influenza Vaccine Market (Forecast Data), by Sector, 2021 – 2030 (Million Units)
      Table 101 RUSSIA & CIS Seasonal Influenza Vaccine Market (Historic Data), by Region, 2010 – 2020 (USD Million)
      Table 102 RUSSIA & CIS Seasonal Influenza Vaccine Market (Forecast Data), by Region, 2021 – 2030 (USD Million)
      Table 103 RUSSIA & CIS Seasonal Influenza Vaccine Market (Historic Data), by Region, 2010 – 2020 (Million Units)
      Table 104 RUSSIA & CIS Seasonal Influenza Vaccine Market (Forecast Data), by Region, 2021 – 2030 (Million Units)
      Table 105 Russia & CIS Seasonal Influenza Vaccine Market (Historic Data), by Types, 2010 – 2030 (USD Million)
      Table 106 Russia & CIS Seasonal Influenza Vaccine Market (Forecast Data), by Types, 2021 – 2030 (USD Million)
      Table 107 Russia & CIS Seasonal Influenza Vaccine Market (Historic Data), by Types, 2010 – 2020 (Million Units)
      Table 108 Russia & CIS Seasonal Influenza Vaccine Market (Forecast Data), by Types, 2021 – 2030 (Million Units)
      Table 109 Russia & CIS Seasonal Influenza Vaccine Market (Historic Data), by Sales Channel, 2010 – 2020 (USD Million)
      Table 110 Russia & CIS Seasonal Influenza Vaccine Market (Forecast Data), by Sales Channel, 2021 – 2030 (USD Million)
      Table 111 Russia & CIS Seasonal Influenza Vaccine Market (Historic Data), by Sales Channel, 2010 – 2020 (Million Units)
      Table 112 Russia & CIS Seasonal Influenza Vaccine Market (Forecast Data), by Sales Channel, 2021 – 2030 (Million Units)
      Table 113 Russia & CIS Seasonal Influenza Vaccine Market (Historic Data), by Sector, 2010 – 2020 (USD Million)
      Table 114 Russia & CIS Seasonal Influenza Vaccine Market (Forecast Data), by Sector, 2021 – 2030 (USD Million)
      Table 115 Russia & CIS Seasonal Influenza Vaccine Market (Historic Data), by Sector, 2010 – 2020 (Million Units)
      Table 116 Russia & CIS Seasonal Influenza Vaccine Market (Forecast Data), by Sector, 2021 – 2030 (Million Units)
      Table 117 Global Seasonal Influenza Vaccine Market - Company Revenue Analysis, 2010 – 2020 (USD Million)
      Table 118 Global Seasonal Influenza Vaccine Market - Company Revenue Share Analysis, 2010 – 2020 (%)
      Table 119 Global Seasonal Influenza Vaccine Market - Company Volume Analysis, 2010 – 2020 (Million Units)
      Table 120 Global Seasonal Influenza Vaccine Market - Company Volume Share Analysis, 2010 – 2020 (%)
      Table 121 Acquisitions and Mergers
      Table 122 Market Drivers – Impact Analysis
      Table 123 Market Restraints
      Table 124 Market Opportunities
      Table 125 Raw Materials Sources of Seasonal Influenza Vaccine Major Manufacturers
      Table 126 Major Buyers of Influenza Vaccine
      Table 127 Distributors/Traders of Influenza Vaccine
      

Industry Major Market Players

  • AstraZeneca
  • Biodiem
  • CSL Limited
  • Emergent BioSolutions
  • F. Hoffmann-La Roche Ltd
  • Gamma Vaccines
  • GlaxoSmithKline
  • Merck
  • Novartis
  • Pfizer
  • Sanofi
  • Sinovac
  • Hualan
  • Abbott
  • Mitsubishi Tanabe Pharma
  • Serum Institute of India
  • Mylan

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2021 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions